Feed Insights Top Reports Pricing

⌘K

08:45:11·35d

ANALYSTRatingvia Quantisnow

HubSpot downgraded by William Blair

ByQuantisnow·Wall Street's wire, on your screen.

HUBS· HubSpot Inc.

Technology

Plus alert sent

Quantisnow Plus members were alerted at 08:45:12 ET - 1.3s after publication.

Sign up for Plus

Free Quantisnow account

Get notified the moment HUBS files

Real-time alerts on SEC filings, FDA approvals, analyst ratings, insider trades, and press releases. Follow any ticker. No credit card.

Sign up free Log in

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HUBS (HubSpot Inc.) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

Director Halligan Brian covered exercise/tax liability with 157 shares, decreasing direct ownership by 0.04% to 353,343 units (SEC Form 4)
Chief Technology Officer Shah Dharmesh covered exercise/tax liability with 577 shares, decreasing direct ownership by 0.04% to 1,294,823 units (SEC Form 4)
Chief Legal Officer Fisher Erika Ashley covered exercise/tax liability with 259 shares, decreasing direct ownership by 2% to 16,011 units (SEC Form 4)
Chief Executive Officer & Pres Rangan Yamini covered exercise/tax liability with 2,622 shares, decreasing direct ownership by 2% to 105,935 units (SEC Form 4)
Chief Financial Officer Bueker Kathryn covered exercise/tax liability with 1,076 shares, decreasing direct ownership by 2% to 57,130 units (SEC Form 4)

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022